Brain drug tested to halt psychosis and protect memory center

This study tested whether adding the epilepsy medication levetiracetam (Keppra) to standard antipsychotic treatment could better control symptoms in people with early psychosis. It involved 65 participants aged 16-40 who had been ill for less than 5 years and still experienced symptoms despite at least 8 weeks of treatment. Researchers measured changes in symptoms, thinking skills, and brain structure over 12 weeks to see if the add-on drug helped.